Gélules FUNGO "Complexe anti-stress" - Complexe CB2
Food supplement declared in France, decision dated 13 August 2026
Gélules FUNGO "Complexe anti-stress" - Complexe CB2 (Novaloa) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Sedum roseum 140 mg per day, Ophiocordyceps sinensis 140 mg per day, Ganoderma lucidum(Curtis 140 mg per day, Magnolia officinalis 25 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Novaloa
- Food business operator placing the product on the market
- Nova CM Distribution
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1 gélule par jour, soit 0,5 g
- Directions for use
- 1 gélule à prendre par jour avec un verre d'eau.
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Liver problems, Taking anticoagulants, Taking antidepressants, Taking diabetes medication, Taking medication, Prolonged use, Children (under 6), Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Nervous system
Declaration 372814, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Sedum roseum (L.) Scop. | Rhizome | Extrait sec alcoolique | 140 mg |
| Ophiocordyceps sinensis | Carpophore | Extrait sec aqueux | 140 mg |
| Ganoderma lucidum(Curtis ex Fr.) P.Karst. | Carpophore | Extrait sec aqueux | 140 mg |
| Magnolia officinalis Rehder & E.H.Wilson | Ecorce | Extrait sec alcoolique | 25 mg |
Other ingredients
huile de noix de coco fractionnée
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Réservé à l'adulte. Déconseillé aux femmes enceintes ou allaitantes. Déconseillé aux personnes sous traitement anticoagulant, antidiabétique ou antihypertenseur sans avis d'un professionnel de santé. En cas de traitement médicamenteux ou de maladie chronique, demander l'avis d'un médecin ou d'un pharmacien avant utilisation. Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants. Les compléments alimentaires ne se substituent pas à une alimentation variée, équilibrée et à un mode de vie sain.
Regulatory points
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Sedum roseum (L.) Scop.
Read the warning, when it applies and the studies cited
RHODIOLA - RHODIOLA ROSEA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).
Sources cited by Health Canada (1)
- EMA 2024: 20 March 2024 EMA/HMPC/24177/2023 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Rhodiola rosea L., rhizoma et radix Final - Revision 1. Amsterdam (NL): European Medicines Agency, Science Medicines Health. [Accessed 2025 January 21]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-rhodiola-rosea-l-rhizoma-et-radix-revision-1_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, hormone replacement therapy (HRT) or birth control medication (HC 2018; Iovieno et al. 2011; Olsson et al. 2009; Brown et al. 2002).
Sources cited by Health Canada (4)
- Brown RP, Gerbarg PL, Ramazanov Z. Rhodiola rosea: A Phytomedicinal Overview. HerbalGram 2002;56:40-52.
- HC 2018: Health Canada. Canada Vigilance Adverse Reaction Online Database. Ottawa (ON): Marketed Health Products Directorate, Health Canada. [Accessed 2025 January 21]. Available from: https://cvp-pcv.hc-sc.gc.ca/arq-rei/index-eng.jsp
- Iovieno, N., Dalton, ED., Fava, M., Mischoulon, D. Second-tier natural antidepressants: review and critique. Journal of Affective Disorders 2011;130(3): 343-357.
- SC 2018: Santé Canada. Base de données en ligne des effets indésirables de Canada Vigilance. Ottawa (ON): Direction des produits de santé commercialisés, Santé Canada. [Consulté le 21 janvier 2025]. Disponible à : https://cvp-pcv.hc-sc.gc.ca/arq-rei/switchlocale.do?lang=fr&url=t.search.recherche
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you have bipolar disorder or bipolar spectrum disorder (Iovieno et al. 2011; Winston and Maimes 2007; Brown et al. 2002).
Sources cited by Health Canada (3)
- Brown RP, Gerbarg PL, Ramazanov Z. Rhodiola rosea: A Phytomedicinal Overview. HerbalGram 2002;56:40-52.
- Iovieno, N., Dalton, ED., Fava, M., Mischoulon, D. Second-tier natural antidepressants: review and critique. Journal of Affective Disorders 2011;130(3): 343-357.
- Winston D, Maimes S. Adaptogens: Herbs for Strength, Stamina, and Stress Relief. Rochester (VT): Healing Arts Press, 2007.
Known adverse reactions
Stop use if you experience irritability or insomnia (Pizzorno and Murray 2006; Kelly 2001).
Sources cited by Health Canada (2)
- Kelly GS. Rhodiola rosea: A Possible Plant Adaptogen. Alternative Medicine Review 2001;6(3): 293-302. PubMed Review article
- Pizzorno JE, Murray MT, editors. Textbook of Natural Medicine. 3rd edition, volume 1. St. Louis (MI): Churchill Livingstone Elsevier; 2006.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Novaloa
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Gélules FUNGO "Complexe anti-stress" - Complexe CB2 (Novaloa): composition and regulation”, https://compoatlas.com/en/supplements/products/372814-gelules-fungo-complexe-anti-stress-complexe-cb2, updated 15 November 2026.